MassDevice.com +5 | The top 5 medtech stories for April 27, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA wants more from Proteus, Otsuka on ‘smart pill’ Otsuka Pharmaceutical and Proteus Digital Health said today that the FDA issued a complete response letter requesting more information from the companies for the combination of the Proteus “smart pill” and Otsuka’s Abilify anti-depressant drug. The Proteus pill is designed to signal a wearable patch after it reaches the stomach, recording and time-stamping data from the pill and other patient metrics. The data can be relayed via Bluetooth to mobile devices and, with consent, to healthcare providers. Read more 4. Boston Scientific chides EU docs for unsupervised Lotus valve implants Boston Scientific today released a field safety notice warning after an investigation identified that a “number of sites” had been performing procedures with the Lotus Valve System without an appropriately trained field clinical specialist. The Marlborough, Mass.-based company said that the presence of a Boston Scientific field clinical specialist is required unless a site is designated as “independent” by the company. Indepe...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news